Regarding the genetic tumor classification, both tumor types develop through different genetic pathways and show different protein expression profiles with the main differentiating factor being IDH1 gene mutations in secondary GBM [1] observed at a frequency of 73% as compared to only 3.7% in primary glioblastomas [1, 28]. Here, IDH1 is linked to glioblastoma.